A phase I trial of the farnesyl transferase inhibitor tipifarnib plus doxorubicin-cyclophosphamide in patients with metastatic breast cancer
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. A. Sparano, U. Hopkins, S. Moulder, L. Vahdat
Institutions: Albert Einstein College of Medicine, Moffitt Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2601126270